These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16635613)

  • 41. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
    Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
    Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I; Mazurek J; Khullar P; Saeed W; Vittorio T; Zolty R
    Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.
    Dschietzig T; Teichman S; Unemori E; Wood S; Boehmer J; Richter C; Baumann G; Stangl K
    J Card Fail; 2009 Apr; 15(3):182-90. PubMed ID: 19327619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 47. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is nesiritide really that good or that bad?
    Cheng TO
    Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525
    [No Abstract]   [Full Text] [Related]  

  • 49. Nesiritide use in pediatric patients with congestive heart failure.
    Feingold B; Law YM
    J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reliability of nesiritide infusion via non-primed tubing and heparin-coated catheters.
    Onat D; Stathopoulos J; Rose A; Newman K; Sciacca RR; Jorde UP; Colombo PC
    Ann Pharmacother; 2005 Oct; 39(10):1617-20. PubMed ID: 16159995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.
    Owan TE; Chen HH; Frantz RP; Karon BL; Miller WL; Rodeheffer RJ; Hodge DO; Burnett JC; Redfield MM
    J Card Fail; 2008 May; 14(4):267-75. PubMed ID: 18474338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nesiritide therapy in a term neonate with renal disease.
    Moffett BS; Jefferies JL; Rossano J; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous nesiritide in acute heart failure.
    Knox MA; Dancy T; Mook W; Pschirer JJ
    Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nesiritide during extracorporeal membrane oxygenation.
    Smith T; Rosen DA; Russo P; Berkenbosch JW; Gustafson RA; Siu BL; Rosen KR; Tobias JD
    Paediatr Anaesth; 2005 Feb; 15(2):152-7. PubMed ID: 15675934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical review and recommendations for nesiritide use in the emergency department.
    Collins SP; Hinckley WR; Storrow AB
    J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 57. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
    Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Administration of nesiritide in patients after coronary artery bypass surgery induces brisk diuresis.
    Benharash P; Omari B
    Am Surg; 2005 Sep; 71(9):794-6. PubMed ID: 16468521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure.
    Peacock WF; Emerman CL; Silver MA
    Am J Emerg Med; 2005 May; 23(3):327-31. PubMed ID: 15915407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Infusion therapy at outpatient clinic in chronic end-stage heart failure].
    Nishi K; Sato Y; Miyamoto T; Taniguchi R; Matsuoka T; Kuwabara Y; Isoda K; Yamane K; Hatakenaka T; Fujinaga K; Fujiwara H; Takatsu Y
    J Cardiol; 2007 May; 49(5):251-8. PubMed ID: 17552290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.